Potential Role of Vitamins A, B, C, D and E in TB Treatment and Prevention: A Narrative Review
Authors:
- Giulia PattiGPGiulia Patti
- Carmen PellegrinoCPCarmen Pellegrino
- Aurelia RicciardiARAurelia Ricciardi
- Roberta NovaraRNRoberta Novara
- Sergio CotugnoSCSergio Cotugno
- Roberta PapagniRPRoberta Papagni
- Giacomo GuidoGGGiacomo Guido
- Valentina TotaroVTValentina Totaro
- Giuseppina De IacoGIGiuseppina De Iaco
- Federica RomanelliFRFederica Romanelli
- Stefania StolfaSSStefania Stolfa
- Maria Letizia MinardiMMMaria Letizia Minardi
Open Access
- 5 November 2021
- journal article
- review article
- Published by MDPI AG in Antibiotics
- Vol. 10 (11) , 1354
Abstract
(1) Background: Tuberculosis (TB) is one of the world’s top infectious killers, in fact every year 10 million people fall ill with TB and 1.5 million people die from TB. Vitamins have an important role in vital functions, due to their anti-oxidant, pro-oxidant, anti-inflammatory effects and to metabolic functions. The aim of this review is to discuss and summarize the evidence and still open questions regarding vitamin supplementation as a prophylactic measure in those who are at high risk of Mycobacterium tuberculosis (MTB) infection and active TB; (2) Methods: We conducted a search on PubMed, Scopus, Google Scholar, EMBASE, Cochrane Library and WHO websites starting from March 1950 to September 2021, in order to identify articles discussing the role of Vitamins A, B, C, D and E and Tuberculosis; (3) Results: Supplementation with multiple micronutrients (including zinc) rather than vitamin A alone may be more beneficial in TB. The WHO recommend Pyridoxine (vitamin B6) when high-dose isoniazid is administered. High concentrations of vitamin C sterilize drug-susceptible, MDR and extensively drug-resistant MTB cultures and prevent the emergence of drug persisters; Vitamin D suppresses the replication of mycobacterium in vitro while VE showed a promising role in TB management as a result of its connection with oxidative balance; (4) Conclusions: Our review suggests and encourages the use of vitamins in TB patients. In fact, their use may improve outcomes by helping both nutritionally and by interacting directly and/or indirectly with MTB. Several and more comprehensive trials are needed to reinforce these suggestions.Keywords
This publication has 109 references indexed in Scilit:
- Oral intake of phenylbutyrate with or without vitamin D3upregulates the cathelicidin LL-37 in human macrophages: a dose finding study for treatment of tuberculosisBMC Pulmonary Medicine, 2013
- Identification of Inhibitors against Mycobacterium tuberculosis Thiamin Phosphate Synthase, an Important Target for the Development of Anti-TB DrugsPLOS ONE, 2011
- Evaluation of NTF1836 as an inhibitor of the mycothiol biosynthetic enzyme MshC in growing and non-replicating Mycobacterium tuberculosisBioorganic & Medicinal Chemistry, 2011
- SLC11A1 (NRAMP1) Polymorphisms and Tuberculosis Susceptibility: Updated Systematic Review and Meta-AnalysisPLOS ONE, 2011
- Mycobacterial lipoprotein activates autophagy via TLR2/1/CD14 and a functional vitamin D receptor signallingCellular Microbiology, 2010
- Mycobacterium tuberculosis Transcriptional Adaptation, Growth Arrest and Dormancy Phenotype Development Is Triggered by Vitamin CPLOS ONE, 2010
- Vitamin C: update on physiology and pharmacologyBritish Journal of Pharmacology, 2009
- 1α,25‐dihydroxyvitamin D3 inhibits matrix metalloproteinases induced by Mycobacterium tuberculosis infectionImmunology, 2009
- Neuropathy caused by B12 deficiency in a patient with ileal tuberculosis: A case reportJournal of Medical Case Reports, 2008
- Total Antioxidant Levels are Low During Active TB and Rise with Anti‐tuberculosis TherapyIUBMB Life, 2004